Literature DB >> 23318957

Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.

John S Albin1, John S Anderson, Jeffrey R Johnson, Elena Harjes, Hiroshi Matsuo, Nevan J Krogan, Reuben S Harris.   

Abstract

APOBEC3F (A3F) and APOBEC3G (A3G) are DNA cytosine deaminases that potently restrict human immunodeficiency virus type 1 replication when the virus is deprived of its accessory protein Vif (virion infectivity factor). Vif counteracts these restriction factors by recruiting A3F and A3G to an E3 ubiquitin (Ub) ligase complex that mediates their polyubiquitination (polyUb) and proteasomal degradation. While previous efforts have identified single amino acid residues in APOBEC3 proteins required for Vif recognition, less is known about the downstream Ub acceptor sites that are targeted. One prior report identified a cluster of polyubiquitinated residues in A3G and proposed an antiparallel model of A3G interaction with the Vif-E3 Ub ligase complex wherein Vif binding at one terminus of A3G orients the opposite terminus for polyUb [Iwatani et al. (2009). Proc. Natl. Acad. Sci. USA, 106, 19539-19544]. To test the generalizability of this model, we carried out a complete mutagenesis of the lysine residues in A3F and used a complementary, unbiased proteomic approach to identify Ub acceptor sites targeted by Vif. Our data indicate that internal lysines are the dominant Ub acceptor sites in both A3F and A3G. In contrast with the proposed antiparallel model, however, we find that the Vif-dependent polyUb of A3F and A3G can occur at multiple acceptor sites dispersed along predicted lysine-enriched surfaces of both the N- and C-terminal deaminase domains. These data suggest an alternative model for binding of APOBEC3 proteins to the Vif-E3 Ub ligase complex and diminish enthusiasm for the amenability of APOBEC3 Ub acceptor sites to therapeutic intervention.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318957      PMCID: PMC3602375          DOI: 10.1016/j.jmb.2013.01.010

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  46 in total

1.  Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field.

Authors:  Elmar Krieger; Günther Koraimann; Gert Vriend
Journal:  Proteins       Date:  2002-05-15

2.  N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.

Authors:  Yudi Wang; Qiujia Shao; Xianghui Yu; Wei Kong; James E K Hildreth; Bindong Liu
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

3.  The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.

Authors:  Shingo Kitamura; Hirotaka Ode; Masaaki Nakashima; Mayumi Imahashi; Yuriko Naganawa; Teppei Kurosawa; Yoshiyuki Yokomaku; Takashi Yamane; Nobuhisa Watanabe; Atsuo Suzuki; Wataru Sugiura; Yasumasa Iwatani
Journal:  Nat Struct Mol Biol       Date:  2012-09-23       Impact factor: 15.369

4.  Universality and structure of the N-end rule.

Authors:  D K Gonda; A Bachmair; I Wünning; J W Tobias; W S Lane; A Varshavsky
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

5.  Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex.

Authors:  Ning Zheng; Brenda A Schulman; Langzhou Song; Julie J Miller; Philip D Jeffrey; Ping Wang; Claire Chu; Deanna M Koepp; Stephen J Elledge; Michele Pagano; Ronald C Conaway; Joan W Conaway; J Wade Harper; Nikola P Pavletich
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

6.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

Authors:  A Gervaix; D West; L M Leoni; D D Richman; F Wong-Staal; J Corbeil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

7.  Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling.

Authors:  Guoqiang Xu; Jeremy S Paige; Samie R Jaffrey
Journal:  Nat Biotechnol       Date:  2010-07-18       Impact factor: 54.908

8.  A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity.

Authors:  Anjie Zhen; Tao Wang; Ke Zhao; Yong Xiong; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

9.  A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.

Authors:  Hongzhan Xu; Evguenia S Svarovskaia; Rebekah Barr; Yijun Zhang; Mohammad A Khan; Klaus Strebel; Vinay K Pathak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

10.  Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.

Authors:  Geng Wu; Guozhou Xu; Brenda A Schulman; Philip D Jeffrey; J Wade Harper; Nikola P Pavletich
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

View more
  16 in total

1.  APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.

Authors:  Roni Nowarski; Ponnandy Prabhu; Edan Kenig; Yoav Smith; Elena Britan-Rosich; Moshe Kotler
Journal:  J Mol Biol       Date:  2014-05-21       Impact factor: 5.469

2.  Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

Authors:  John S Albin; William L Brown; Reuben S Harris
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

3.  Mass spectrometry-based proteomic approaches for discovery of HIV-host interactions.

Authors:  Yang Luo; Mark A Muesing
Journal:  Future Virol       Date:  2014       Impact factor: 1.831

4.  A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.

Authors:  Shivender M D Shandilya; Markus-Frederik Bohn; Celia A Schiffer
Journal:  Virology       Date:  2014-10-29       Impact factor: 3.616

5.  ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.

Authors:  Ruth Hüttenhain; Jiewei Xu; Lily A Burton; David E Gordon; Judd F Hultquist; Jeffrey R Johnson; Laura Satkamp; Joseph Hiatt; David Y Rhee; Kheewoong Baek; David C Crosby; Alan D Frankel; Alexander Marson; J Wade Harper; Arno F Alpi; Brenda A Schulman; John D Gross; Nevan J Krogan
Journal:  Cell Host Microbe       Date:  2019-06-25       Impact factor: 21.023

6.  Differential Contributions of Ubiquitin-Modified APOBEC3G Lysine Residues to HIV-1 Vif-Induced Degradation.

Authors:  Tiffany Turner; Qiujia Shao; Weiran Wang; Yudi Wang; Chenliang Wang; Ballington Kinlock; Bindong Liu
Journal:  J Mol Biol       Date:  2016-06-10       Impact factor: 5.469

7.  APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.

Authors:  Amy M Molan; Heather M Hanson; Cynthia M Chweya; Brett D Anderson; Gabriel J Starrett; Christopher M Richards; Reuben S Harris
Journal:  Virology       Date:  2017-08-23       Impact factor: 3.616

Review 8.  Cullin E3 ligases and their rewiring by viral factors.

Authors:  Cathal Mahon; Nevan J Krogan; Charles S Craik; Elah Pick
Journal:  Biomolecules       Date:  2014-10-13

Review 9.  Suppression of APOBEC3-mediated restriction of HIV-1 by Vif.

Authors:  Yuqing Feng; Tayyba T Baig; Robin P Love; Linda Chelico
Journal:  Front Microbiol       Date:  2014-08-26       Impact factor: 5.640

10.  Peptide level immunoaffinity enrichment enhances ubiquitination site identification on individual proteins.

Authors:  Veronica G Anania; Victoria C Pham; XiaoDong Huang; Alexandre Masselot; Jennie R Lill; Donald S Kirkpatrick
Journal:  Mol Cell Proteomics       Date:  2013-10-18       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.